Course Moderator / Coordinator
M.-P Revel
Paris/FR
Registration information
All ESOR 2023 Foundation Courses are included in the ESR Premium Education Package 2023, which provides access to numerous educational services such as Education on Demand, Eurorad, and content on ESR Connect.
For more details, please visit the ESR Premium Education Package Area
CME accreditation
ONLY for Live Streaming
The course has been granted
5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.
Certificates with CME credits will be issued only after watching the live stream and completing an online evaluation form.
No CME credits will be available for watching on demand.
ESOR Foundation Course
CHEST IMAGING | Online | May 10, 2023 | 12:30 – 18:00 CEST
Course Information
This course is aimed at residents in their 4th and 5th year of training in radiology and recently board-certified radiologists interested in Chest Imaging. It is strictly adhered to Level II of the European Training Curriculum and is designed to provide the essentials of current state-of the-art imaging, diagnostic algorithms and their appropriateness, in the initial staging of lung cancer and follow-up of systemic therapies. It is also important to become familiar with atypical presentations of lung cancer and the management of incidental findings in thoracic oncology. CT has a major role in patients with severe haemoptysis, a potentially life-threatening condition. Finally, CT can approach the accurate diagnosis of diffuse cystic disease of the lung.
Learning objectives
-
To learn about initial CT staging, management of incidental findings and assessment of response to treatment on CT in lung cancer patients
-
To learn how CT helps reduce differential diagnoses in cystic lung disease.
-
To learn about the role of CT in patients with severe haemoptysis
Programme Online
Wednesday, May 10, 2023
| 12:30-13:10 |
Lung cancer: initial staging and TNM classification A.R Larici, Rome/IT |
| 13:10-13:50 |
Lung cancer: atypical presentations I. Hartmann, Rotterdam/NL |
| 13:50-14:30 |
Haemoptysis: what is the role of CT? M.-P Revel, Paris/FR |
| 14:30-15:00 | Q&A |
| 15:00-15:30 | BREAK |
| 15:30-16:10 |
Response to systemic therapy: RECIST and Irecist criteria, pulmonary toxicity. A.R Larici, Rome/IT |
| 16:10-16:50 |
Incidental findings in thoracic oncology I. Hartmann, Rotterdam/NL |
| 16:50-17:30 |
Cystic lung diseases: easy to diagnose! M.-P Revel, Paris/FR |
| 17:30-18:00 | Q&A |